Cargando…

P1434: CORRECTION OF CONGENITAL NEUTROPENIA-RELATED GENES IN NAÏVE IPS CELLS DERIVED FROM PATIENTS USING VIRAL-FREE CRISPR/CAS9 GENE-EDITING SYSTEM

Detalles Bibliográficos
Autores principales:	Krzyzanowski, D., Rydzynska, Z., Pawlik, B., Dobrewa, W., Grzela, D., Mlynarski, W., Madzio, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429466/ http://dx.doi.org/10.1097/01.HS9.0000848592.96984.59

Ejemplares similares

Neutrophil Elastase Defects in Congenital Neutropenia
por: Rydzynska, Zuzanna, et al.
Publicado: (2021)

P808: CONGENITAL NEUTROPENIA PREVALENCE AMONG POLISH CHILDREN – SUMMARY OF A NATIONWIDE GENETIC SCREENING CAMPAIGN
por: Bąbol-Pokora, K., et al.
Publicado: (2022)

Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing
por: Li, Fan, et al.
Publicado: (2020)

Applications of the CRISPR/Cas system beyond gene editing
por: Anton, Tobias, et al.
Publicado: (2018)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

CRISPR/Cas9 Essential Gene Editing in Drosophila
por: Osadchiy, I. S., et al.
Publicado: (2023)

CRISPR/Cas9-mediated genome editing in naïve human embryonic stem cells
por: Jacobs, Eva Z., et al.
Publicado: (2017)

Editing of the urease gene by CRISPR-Cas in the diatom Thalassiosira pseudonana
por: Hopes, Amanda, et al.
Publicado: (2016)

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023)

CRISPR/Cas9-gene editing approaches in plant breeding
por: Saini, Himanshu, et al.
Publicado: (2023)

The enhancement of CRISPR/Cas9 gene editing using metformin
por: Rollins, Jaedyn L., et al.
Publicado: (2023)

Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing
por: Tang, Jia-Xin, et al.
Publicado: (2021)

CRISPR-Cas9 Gene Editing of the Sal1 Gene Family in Wheat
por: Mohr, Toni, et al.
Publicado: (2022)

Qualitative and Quantitative Detection of CRISPR-Associated Cas Gene in Gene-Edited Foods
por: Ding, Lin, et al.
Publicado: (2023)

Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing
por: Gumerson, Jessica D., et al.
Publicado: (2021)

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
por: Liang, Puping, et al.
Publicado: (2015)

Outbred genome sequencing and CRISPR/Cas9 gene editing in butterflies
por: Li, Xueyan, et al.
Publicado: (2015)

Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
por: Cheong, Taek-Chin, et al.
Publicado: (2016)

Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders
por: Im, Wooseok, et al.
Publicado: (2016)

Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017)

Gene Editing and Crop Improvement Using CRISPR-Cas9 System
por: Arora, Leena, et al.
Publicado: (2017)

Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018)

Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019)

In Vitro Pre-validation of Gene Editing by CRISPR/Cas9 Ribonucleoprotein
por: Mehravar, Maryam, et al.
Publicado: (2019)

Gene editing using CRISPR-Cas9 for the treatment of lung cancer
por: Castillo, Andres
Publicado: (2016)

CRISPR/Cas9 Gene Editing: An Unexplored Frontier for Forest Pathology
por: Dort, Erika N., et al.
Publicado: (2020)

CRISPR/Cas: a potential gene-editing tool in the nervous system
por: Gao, Yanxia, et al.
Publicado: (2020)

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
por: Mirgayazova, Regina, et al.
Publicado: (2020)

AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
por: Richards, Daelyn Y., et al.
Publicado: (2019)

Various Aspects of a Gene Editing System—CRISPR–Cas9
por: Janik, Edyta, et al.
Publicado: (2020)

CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing
por: Dasgupta, Ishani, et al.
Publicado: (2021)

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics
por: Liu, Wenyi, et al.
Publicado: (2021)

Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives
por: Dehshahri, Ali, et al.
Publicado: (2021)

How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research
por: Johansen, Kristoffer Haurum
Publicado: (2022)

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2022)

Mini-Review: Transgenerational CRISPR/Cas9 Gene Editing in Plants
por: Impens, Lennert, et al.
Publicado: (2022)

Reversible RNA acylation for control of CRISPR–Cas9 gene editing
por: Habibian, Maryam, et al.
Publicado: (2019)

Application of CRISPR-Cas9 gene editing for congenital heart disease
por: Seok, Heeyoung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i7copa7pkhunpu7flsn5dktqs7